Infiltrating memory/senescent T cell ratio predicts extrahepatic metastasis of hepatocellular carcinoma

Annals of Surgical Oncology

Volumn 19, Issue 2, 2012, Pages 455-466

  Gao, Qiang ^a   Zhou, Jian ^a,b   Wang, Xiao Ying ^a   Qiu, Shuang Jian ^a   Song, Kang ^a   Huang, Xiao Wu ^a   Sun, Jian ^a   Shi, Ying Hong ^a   Li, Bai Zhou ^c   Xiao, Yong Sheng ^a   Fan, Jia ^a,b  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^c THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIBODY; CD45RO ANTIGEN; CD57 ANTIGEN; CD83 ANTIGEN; CHLORDANE; T6 ANTIGEN; TRANSCRIPTION FACTOR FOXP3;

ADULT; ARTICLE; CANCER SPECIFIC SURVIVAL; CD3+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEMORY T LYMPHOCYTE; MULTIVARIATE ANALYSIS; RECURRENCE FREE SURVIVAL; TISSUE MICROARRAY; TUMOR ASSOCIATED LEUKOCYTE; UNIVARIATE ANALYSIS;

CARCINOMA, HEPATOCELLULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOLOGIC MEMORY; LIVER NEOPLASMS; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE; T-LYMPHOCYTES;

EID: 84856673287     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-1864-3     Document Type: Article

References (38)

1. A Jemal F Bray M Center, et al. 2011 Global cancer statistics CA Cancer J Clin. 61 69 90 21296855 10.3322/caac.20107
2. M Sherman 2008 Recurrence of hepatocellular carcinoma N Engl J Med. 359 2045 2047 18923166 10.1056/NEJMe0807581 1:CAS:528:DC%2BD1cXhtleis77E
3. A Villanueva Y Hoshida S Toffanin, et al. 2010 New strategies in hepatocellular carcinoma: genomic prognostic markers Clin Cancer Res. 16 4688 4694 20713493 10.1158/1078-0432.CCR-09-1811 1:CAS:528:DC%2BC3cXht1aktbvE
4. RTP Poon 2009 Differentiating early and late recurrences after resection of HCC in cirrhotic patients: implications on surveillance, prevention, and treatment strategies Ann Surg Oncol. 16 792 794 19190964 10.1245/s10434-009- 0330-y
5. M Natsuizaka T Omura T Akaike, et al. 2005 Clinical features of hepatocellular carcinoma with extrahepatic metastases J Gastroenterol Hepatol. 20 1781 1787 16246200 10.1111/j.1440-1746.2005.03919.x
6. MS Si F Amersi SR Golish, et al. 2003 Prevalence of metastases in hepatocellular carcinoma: risk factors and impact on survival Am Surg. 69 879 885 14570367
7. M Kawamura J Nakajima H Matsuguma, et al. 2008 Surgical outcomes for pulmonary metastases from hepatocellular carcinoma Eur J Cardiothorac Surg. 34 196 199 18455409 10.1016/j.ejcts.2008.03.056
8. M Kanda R Tateishi H Yoshida, et al. 2008 Extrahepatic metastasis of hepatocellular carcinoma: incidence and risk factors Liver Int. 28 1256 1263 18710423 10.1111/j.1478-3231.2008.01864.x 1:CAS:528:DC%2BD1cXht1CmtbvE
9. C Berasain J Castillo MJ Perugorria, et al. 2009 Inflammation and liver cancer: new molecular links Ann N Y Acad Sci. 1155 206 221 19250206 10.1111/j.1749-6632.2009.03704.x 1:CAS:528:DC%2BD1MXktFKltrk%3D
10. V Chew C Tow M Teo, et al. 2010 Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patients J Hepatol. 52 370 379 19720422 10.1016/j.jhep.2009.07.013 1:CAS:528: DC%2BC3cXisFejtr0%3D
11. XD Zhu JB Zhang PY Zhuang, et al. 2008 High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma J Clin Oncol. 26 2707 2716 18509183 10.1200/JCO.2007.15.6521
12. Q Gao SJ Qiu J Fan, et al. 2007 Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection J Clin Oncol. 25 2586 2623 17577038 10.1200/JCO.2006.09.4565
13. YH Shi WX Ding J Zhou, et al. 2008 Expression of X-linked inhibitor-of-apoptosis protein in hepatocellular carcinoma promotes metastasis and tumor recurrence Hepatology. 48 497 507 18666224 10.1002/hep.22393 1:CAS:528:DC%2BD1cXhtVCqt7rE
14. Internatinal Union Against Cancer (UICC). Sobin LH, Wittekind C, eds. TNM classification of malignant tumors. 6th ed. New York: Wiley-Liss. 2002; p. 81-3.
15. J Fan GS Yang ZR Fu, et al. 2009 Liver transplantation outcomes in 1, 078 hepatocellular carcinoma patients: a multi-center experience in Shanghai, China J Cancer Res Clin Oncol. 135 1403 1412 19381688 10.1007/s00432-009-0584-6
16. J Zhou Z Wang ZQ Wu, et al. 2008 Sirolimus-based immunosuppression therapy in liver transplantation for patients with hepatocellular carcinoma exceeding the Milan criteria Transplant Proc. 40 3548 3553 19100435 10.1016/j.transproceed.2008.03.165 1:STN:280:DC%2BD1M%2Fkt12qsw%3D%3D
17. V Mazzaferro JM Llovet R Miceli, et al. 2009 Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis Lancet Oncol. 10 35 43 19058754 10.1016/S1470-2045(08)70284-5
18. JF Emile R Adam M Sebagh, et al. 2000 Hepatocellular carcinoma with lymphoid stroma: a tumour with good prognosis after liver transplantation Histopathology. 37 523 529 11122434 10.1046/j.1365-2559.2000.00952.x 1:STN:280:DC%2BD3M7hvFWiuw%3D%3D
19. E Unitt A Marshall W Gelson, et al. 2006 Tumour lymphocytic infiltrate and recurrence of hepatocellular carcinoma following liver transplantation J Hepatol. 45 246 253 16580084 10.1016/j.jhep.2005.12.027 1:CAS:528: DC%2BD28Xmslylurk%3D
20. CA Michie A McLean C Alcock, et al. 1992 Lifespan of human lymphocyte subsets defined by CD45 isoforms Nature 360 6401 264 265 1436108 10.1038/360264a0 1:STN:280:DyaK3s%2Fmtlelug%3D%3D
21. F Pages A Berger M Camus, et al. 2005 Effector memory T cells, early metastasis, and survival in colorectal cancer N Engl J Med. 353 2654 2666 16371631 10.1056/NEJMoa051424 1:CAS:528:DC%2BD2MXhtlarsrrE
22. F Pages A Kirilovsky B Mlecnik, et al. 2009 In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer J Clin Oncol. 27 5944 5951 19858404 10.1200/JCO.2008.19.6147 1:CAS:528: DC%2BC3cXhtVWisL8%3D
23. DL Woodland JE Kohlmeier 2009 Migration, maintenance and recall of memory T cells in peripheral tissues Nat Rev Immunol. 9 153 161 19240755 10.1038/nri2496 1:CAS:528:DC%2BD1MXit1yjsLs%3D
24. L Bird 2009 T cell memory: live long with WNT Nat Rev Immunol. 9 460 461 10.1038/nri2594 1:CAS:528:DC%2BD1MXns1CqsrY%3D
25. P Beckhove M Feuerer M Dolenc, et al. 2004 Specifically activated memory T cell subsets from cancer patients recognize and reject xenotransplanted autologous tumors J Clin Invest. 114 67 76 15232613 1:CAS:528: DC%2BD2cXls1altLs%3D
26. + T cells confer superior antitumor immunity compared with effector memory T cells Proc Natl Acad Sci U S A. 102 9571 9576 15980149 10.1073/pnas.0503726102 1:CAS:528:DC%2BD2MXmsVakt7o%3D
27. G Casorati F Locatelli S Pagani, et al. 2005 Bone marrow-resident memory T cells survive pretransplant chemotherapy and contribute to early immune reconstitution of patients with acute myeloid leukemia given mafosfamide-purged autologous bone marrow transplantation Exp Hematol. 33 212 218 15676215 10.1016/j.exphem.2004.10.008 1:CAS:528:DC%2BD2MXoslKnsQ%3D%3D
28. + NK-cell subset Blood. 116 3865 3874 20733159 10.1182/blood-2010-04-282301 1:CAS:528:DC%2BC3cXhsFahsbzO
29. + lymphocyte levels may predict outcome in melanoma patients treated with adjuvant interferon-α Anticancer Res. 28 2B 1139 1142 18505049 1:CAS:528:DC%2BD1cXmt1ehtLw%3D
30. + lymphocyte subset in interferon therapy of patients with renal cell carcinoma Anticancer Res 22 6B 3679 3683 12552976
31. T Alvaro M Lejeune MT Salvado, et al. 2006 Immunohistochemical patterns of reactive microenvironment are associated with clinicobiologic behavior in follicular lymphoma patients J Clin Oncol. 24 5350 5357 17135637 10.1200/JCO.2006.06.4766
32. + T lymphocytes in the peripheral blood of patients with advanced gastric cancer Int J Clin Oncol. 13 528 535 19093181 10.1007/s10147-008-0789-8 1:CAS:528:DC%2BD1cXhsFSrurjF
33. + T lymphocytes and functional immune deficiency J Leukoc Biol. 87 107 116 19880576 10.1189/jlb.0809566 1:CAS:528:DC%2BC3cXit1ajsw%3D%3D
34. D Focosi M Petrini 2007 CD57 expression on lymphoma microenvironment as a new prognostic marker related to immune dysfunction J Clin Oncol. 25 1289 1291 17401023 10.1200/JCO.2006.10.2251
35. CL Montes AI Chapoval J Nelson, et al. 2008 Tumor-induced senescent T cells with suppressor function: a potential form of tumor immune evasion Cancer Res. 68 870 879 18245489 10.1158/0008-5472.CAN-07-2282 1:CAS:528: DC%2BD1cXhtlygtL4%3D
36. + enriched "young" tumor infiltrating lymphocytes can mediate regression of metastatic melanoma Clin Cancer Res. 16 6122 6131 20668005 10.1158/1078-0432. CCR-10-1297 1:CAS:528:DC%2BC3cXhsFOjtr%2FM
37. W Gelson M Hoare S Vowler, et al. 2010 Features of immune senescence in liver transplant recipients with established grafts Liver Transpl. 16 577 587 20440767
38. A Budhu M Forgues QH Ye, et al. 2006 Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment Cancer Cell. 10 99 111 16904609 10.1016/j.ccr.2006.06.016 1:CAS:528:DC%2BD28XovVKqur0%3D